BitMine Raises $300M in Preferred Stock to Buy ETH
BitMine plans a $300 million perpetual preferred stock sale to acquire ETH, expand staking infrastructure, and invest...
Zero Based Budgeting Concepts For Dummies
This piece covers core Zero Based Budgeting concepts in plain language, highlighting how to apply them to real-life budgeting scenarios.
15,663 articlesPrediction: Palantir Stock Will Hit New Highs This Year
A wave of optimistic notes suggests Palantir stock will push toward higher ground this year, underpinned by AI-driven...
Nearly Half of Workers 55 and Older Aren’t Using AI at Work
A fresh survey shows nearly half of workers 55 and older aren’t planning to use AI in their jobs. The piece outlines ...
Concrete Pumping Holdings Rocketed Amid Market Mayhem
On a day when markets slid on inflation fears, one small-cap stock surprised investors by rocketing higher. Here’s wh...
Should Metals Company While Below $7? A Practical Investor Guide
TMC trades under $7 as investors weigh the potential of seabed mining for essential metals. This guide breaks down th...
Which Better Artificial Intelligence ETFs: CHAT and XLK
AI investing can take two paths: a targeted, actively managed approach with CHAT or a broad, low-cost tech track with...
Asked CHATGPT: Will BTC Inevitably Break the $60K Floor?
Bitcoin dived to around $59,000, briefly erasing hundreds of billions in value before rebounding. Analysts debate whe...
69-Year-Old Widow with $890,000 IRA Faces Massive Tax Bill
In a timely example, the 69-year-old widow with $890,000 in an inherited IRA faces a decision that could trigger six ...
Investors: This Might Be the Easiest Way to Buy SpaceX OpenAI Anthropic
The AI IPO buzz around SpaceX, OpenAI, and Anthropic can tempt bold moves. A steadier path for investors is broad-mar...
Inside Mouth-Watering Numbers Justifying SpaceX IPO Value
SpaceX aims for a $1.75 trillion IPO, triggering a fierce debate among analysts about whether growth, cash flow, and ...
OpenAI Gets Kneecapped by Major Investor: Market Turmoil
OpenAI confronts multi-front pressure as its largest backer rethinks bets, Microsoft shifts workloads inward, and riv...
CRISPR Therapeutics $2.4 Billion Cash: Why the Stock Slump Persists
CRISPR Therapeutics wields a rare card: a cash-rich balance sheet and an approved gene therapy. But the stock refuses...
Popular Topics
Fable
Smart Money Moves For Everyday Life
Investment Strategies In Energy Sector
Best Index Funds For Retirement
Investment Strategies
Untitled D6eff7ea
Crypto For Beginners
Best Dividend Etfs
Index
Innovative Skincare Clinical
Dutch Salary
Blue Owl
Budget
Ai Healthcare News
Penalty Vs No Penalty Depending On Lock Status